ARTICLE | Clinical News
CVT-1: Began Phase I trial
February 14, 1994 8:00 AM UTC
CV Therapeutics Inc., Mountain View, Calif. Product: CVT-1 orally active sulfated polysaccharide that blocks a transport protein that carries cholesterol across the intestine Indication: High serum ch...